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Abstract
Dosage compensation of the mammalian X chromosome (X) was proposed by Susumu Ohno as a mechanism wherein the inac-
tivation of one X in females would lead to doubling the expression of the other. This would resolve the dosage imbalance between
eutherian females (XX) versus male (XY) and between a single active X versus autosome pairs (A). Expression ratio of X- and A-linked
geneshasbeenrelativelywell studied inhumansandmice,despite controversial resultsover theexistenceofupregulationofX-linked
genes. Here we report the first comprehensive test of Ohno’s hypothesis in bovine preattachment embryos, germline, and somatic
tissues. Overall an incomplete dosage compensation (0.5<X:A< 1) of expressed genes and an excess X dosage compensation
(X:A> 1) of ubiquitously expressed “dosage-sensitive” genes were seen. No significant differences in X:A ratios were observed
between bovine female and male somatic tissues, further supporting Ohno’s hypothesis. Interestingly, preimplantation embryos
manifesteda unique pattern of X dosage compensation dynamics. Specifically, X dosage decreased after fertilization, indicating that
the sperm brings in an inactive X to the matured oocyte. Subsequently, the activation of the bovine embryonic genome enhanced
expression of X-linked genes and increased the X dosage. As a result, an excess compensation was exhibited from the 8-cell stage to
the compact morula stage. The X dosage peaked at the 16-cell stage and stabilized after the blastocyst stage. Together, our findings
confirmOhno’shypothesisofXdosagecompensation in thebovineandextend itby showing incompleteandover-compensationfor
expressed and “dosage-sensitive” genes, respectively.
Key words: Ohno’s hypothesis, X dosage compensation, preattachment embryos, bovine.
Introduction
Gene dosage is the number of copies of a given gene in cells
of an organism and can be manifested by the amount of its
products (Ercan 2015). Maintenance of proper gene dosage is
essential in functional cellular networks such as in
embryogenesis, and fetus development. Aneuploidy such as
monosomy or trisomy is an abnormal change in the dosage of
chromosomes and is generally detrimental to the organism
(Holtzman et al. 1992). For example, aneuploidy accounts for
46.3% of spontaneous abortions in humans (Hassold et al.
 The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
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1980). Small changes in dosage of single genes can lead to
many diseases (Hurles et al. 2008) and the onset of tumorigen-
esis (Gordon et al. 2012). However, monosomy of the X chro-
mosome in mammalian males is well tolerated, although over a
thousand genes important for both sexes are located on X
(Ercan 2015). Susumu Ohno hypothesized that to prevent
the deleterious effects of haploinsufficiency in males, a com-
pensatory mechanism involving the doubling expression of X-
linked genes must occur (Ohno et al. 1959). This, however, at
the same time could cause a quadruple dosage of X in females.
By transcriptionally silencing one of the two X chromosomes in
females the dosage of the X chromosome between males and
females is balanced (Veitia and Potier 2015). Meanwhile, this
also balances the gene dosage between sex chromosome and
autosome pairs (A) in both sexes (Ohno 1966).
Although X chromosome inactivation (XCI) has been ob-
served in all mammalian species studied to date (Ohno et al.
1959; Lyon 1961; Heard et al. 1997), dosage compensation
by doubling the expression of X-linked genes has only been
studied in very few species and is still heavily debated (Nguyen
and Disteche 2006; Xiong et al. 2010; Deng et al. 2011; He
et al. 2011; Kharchenko et al. 2011). Dosage compensation is
determined by calculating the ratio of averaged expression
value of X-linked genes to that of the autosomes (X:A ratio).
The ratio X:A |1 indicates the doubling of X gene expression,
while X:A of 0.5 rejects Ohno’s hypothesis. Two previous mi-
croarray studies fully supported dosage compensation in both
humans and mice (Gupta et al. 2006; Nguyen and Disteche
2006). However, the first RNA sequencing (RNA-seq) study of
humans and mice (Xiong et al. 2010) claimed that microarray-
based expression was not suitable for comparing expression
levels of different genes, and reported X:A of approximately
0.5, that is, a lack of dosage compensation. Subsequently, the
same RNA-seq data were re-analyzed with all low and non-
expressed genes removed because such genes are enriched
on X chromosomes and thus could skew the comparison.
Results from such filtering verified the hypothesis (Deng
et al. 2011; Kharchenko et al. 2011). Since then, Ohno’s hy-
pothesis has been tested with many different analysis
approaches including comparing the ratio between the mod-
ern X to the proto XX using 1:1 orthologs between humans
and chickens (Lin et al. 2012) or comparing only genes coding
for large proteins as the “dosage-sensitive housekeeping gen-
es” (Pessia, Engelst€adter, et al. 2014). It has been found that
different experimental platforms, analysis methods, and cut-
off values all influenced the dosage compensation results.
Thus, more questions than answers are presented on the evo-
lution of dosage compensation of sex chromosomes (He and
Zhang 2016).
While debates persist over dosage compensation, XCI has
been observed in all mammalian species studied to date
(Okamoto et al. 2011). In the bovine, XCI was proposed by
De La Fuente et al. (1999), and confirmed by Xue et al. (2002).
In early bovine embryos imprinted XCI was observed at the
morula stage (Ferreira et al. 2010) and random XCI occurred
between the blastocyst and elongation stages (Bermejo-
Alvarez et al. 2011). Although a recent study reported incom-
plete X dosage compensation in bovine fat, liver, muscle, and
pituitary gland (Ka et al. 2016), further studies are needed for
bovine early embryos and germ cells.
Here we report the first comprehensive test of Ohno’s hy-
pothesis in the compensatory upregulation of the X chromo-
some in bovine embryos, germline, and a vast array of somatic
tissues using seven RNA-seq data sets (three from bovine
preattachment embryos and four from somatic tissues), in-
cluding immature and mature oocytes, in vivo and in vitro
embryos up to the blastocyst stage (days 1–7; day
0¼ standing estrus), conceptuses (embryos and associated
extra-embryonic membranes) from day 7 to day 19, two adult
female-specific tissues, eight adult female and male somatic
tissues. Using median expression of the X:A ratio with its 95%
bootstrap confidence intervals, we report incomplete com-
pensatory upregulation of expressed X-linked genes and com-
plete dosage compensation of “dosage-sensitive” genes. Our
data thus fully support Ohno’s hypothesis in that the com-
pensatory upregulation of X chromosome expression affects
“dosage-sensitive” genes in bovine developing embryos,
germline cells, and female/male tissues.
Materials and Methods
Paralog Analysis
To determine the unique or nonunique mapping strategy, we
first calculated paralog enrichment on each bovine chromo-
some. Paralogs were identified on BioMart (Ensembl genome
browser: http://useast.ensembl.org/biomart/; ensemble genes
85) and defined as genes with greater than 70% amino acid
identity. This minimal cut-off for paralogs was a result of our
pervious study, which determined that 70% was the best
match of the BioMart search algorithm for the identification
of X-linked multigene families (Jue et al. 2013). The total
number of genes on each chromosome was calculated
using bovine genome reference annotation UMD3.1 (http://
useast.ensembl.org/Bos_taurus/Info/Annotation?redirect¼
no). Enrichment of paralogs gene number for each auto-
some was calculated by Fisher’s exact test compared with
that on X chromosome (table 1).
RNA-seq Data Sets and Read Trimming
Raw FASTQ files were obtained from NCBI GEO database
(table 2). A total of seven data sets including (1) in vivo de-
veloped matured oocytes and 2-cell to blastocyst stage pre-
implantation embryos (Jiang et al. 2014), (2) immature
oocyte, in vitro developed matured oocytes, 4-cell, 8-
cell, 16-cell, and blastocyst embryos (Graf et al. 2014),
(3) conceptuses at days 7, 10, 13, 16, and 19 (embryos
and associated extra-embryonic membranes) (Mamo et al.
Duan et al. GBE
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2012), (4) female endometria and corpora lutea (CL)
(Moore et al. 2016), (5) female somatic tissues of brain,
liver, muscle, and kidney (Chen et al. 2015), (6) male so-
matic tissues of fat, muscle, hypothalamus, duodenum,
liver, lung, and kidney (PRJEB6377), and (7) female and
male somatic tissues of fat, liver, muscle, and pituitary
gland (Seo et al. 2016).
All RNA-seq raw reads were downloaded from NCBI using
sratoolkit (version 2.5.0; http://www.ncbi.nlm.nih.gov/Traces/
sra/sra.cgi?view¼ toolkit_doc&f¼ std#s-2). The sequence
read archive (sra) format files were converted to fastq format
by fastq-dump (version 2.5.0; http://www.ncbi.nlm.nih.
gov/Traces/sra/sra.cgi?view¼ toolkit_doc&f¼ fastq-dump).
Quality trimming and control were conducted as follows be-
fore mapping to the reference genome. First, Trimmomatic
(version 0.33; http://www.usadellab.org/cms/?page¼ trim-
momatic) was applied to removing the universal sequencing
adaptors of SOLiD and Illumina in respective data sets with a
minimum Phred score of 20 and minimal length of 30 bp.
Subsequently, read quality was examined using FastQC (ver-
sion 0.11.3; http://www.bioinformatics.babraham.ac.uk/proj-
ects/fastqc/). The summary of the numbers of reads in each
sample after trimming is presented in supplementary table S1,
Supplementary Material online. The average number of read
input for mapping across all samples is 22,814,027.
Mapping and Transcript Assembly
RNA-seq read mapping and transcript assembly were pre-
formed based on the following pipeline. Trimmed RNA-seq
reads were aligned to Ensemble bovine reference genome
assembly UMD3.1.1 using Hisat2 version 2.0.5 aligner
(Pertea et al. 2016). Transcript splice site detection was used
and both unique and nonuniquely mapped reads were kept
for the subsequent analysis. The percentages of nonuniquely
mapped reads for each sample are summarized in supple-
mentary table S1, Supplementary Material online, and the
averaged overall mapping rate was 83.5%. IsoEM version
1.1.5 (Nicolae et al. 2011) was used to quantify gene expres-
sion to transcripts per kilobase million (TPM) using default
parameters. For nonuniquely mapped reads, IsoEM assign
fractions of the multiple aligned reads to each location using
an expectation maximization algorithm (Nicolae et al. 2011).
Expressed genes were defined as expression level TPM> 1.
“Dosage-sensitive” genes were selected as ubiquitously
expressed genes (TPM> 1) throughout all somatic samples
or embryonic sample.
RNA-seq Data Set Overview
Matrices of gene expression TPM for the embryo (data sets
1–3) and somatic tissues (data sets 4–8) were processed sep-
arately in R to identify ubiquitous genes. Correlation plots and
unsupervised hierarchical clustering were conducted in R for
quality control and identification of biologically distinct sub-
groups. Outliers in the biological replicates were removed for
the downstream analysis.
The chromosome-wide gene expression distributions were
isolated by gene locations on each chromosome in all samples
using log2-transformed TPM (TPM> 1), the boxplots for the
distribution were made in R.
GO Analysis
Gene ontology enrichment analysis was performed in DAVID
(Huang et al. 2009) and 245 and 7,603 genes on the X and
Table 1
The Enrichment of Paralogs on Bovine Autosomes and the X Chromosome
Chromosome Total Number
of Genes
Number (%) of Paralogs P-Value Chromosome Total Number
of Genes
Number (%)
of Paralogs
P-Value
1 985 167 (17) 5.65e-18 16 710 129 (18) 6.56e-13
2 1,021 229 (22) 1.88e-08 17 665 149 (22) 6.55e-07
3 1,372 314 (23) 7.24e-09 18 1,236 207 (17) 1.20e-20
4 855 222 (26) 0.00031 19 1,347 303 (22) 2.13e-09
5 1,323 336 (25) 1.51e-05 20 384 91 (24) 0.00027
6 692 156 (23) 6.65e-07 21 731 221 (30) 0.10
7 1,396 377 (27) 0.00046 22 608 110 (18) 6.40e-12
8 829 230 (28) 0.0059 23 785 264 (34) 0.61
9 602 146 (24) 6.45e-05 24 347 98 (28) 0.049
10 1,074 316 (29) 0.033 25 766 102 (13) 7.22e-24
11 1,047 192 (18) 1.63e-15 26 437 82 (19) 5.63e-09
12 414 98 (24) 0.00018 27 274 73 (27) 0.022
13 850 185 (22) 1.31e-08 28 355 78 (22) 3.08e-05
14 571 135 (24) 2.76e-05 29 705 186 (26) 0.0012
15 1,050 387 (37) 0.97 X 1,128 374 (33)
Genome average 819 199 (24) 1.46e-05
Dosage Compensation of the X Chromosomes GBE
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autosomes, respectively, were found as ubiquitous in the so-
matic tissue data sets. Similarly, 117 and 3,947 genes on the X
and autosomes, respectively, were found as ubiquitous in the
embryo data sets. The P-values in top 10 biological processes
were plotted using plotly (https://plot.ly) in R. Pie charts for
biological processes were generated as described by The Gene
Ontology Consortium (Gene Ontology Consortium 2015).
X:A Ratio Calculation
When calculating the X:A ratio, we applied the pairwiseCI
package in R (Schaarschmidt and Gerhard 2015) to obtain a
95% confidence interval for the ratio of the median of X to
the median of A as in a previous study (Sangrithi et al. 2017). It
is based on 1,000 bootstrap replicates where sampling from
the original data was done with replacement and stratified by
the group variables. Bootstrapping (Efron and Tibshirani
1994) was used because it is simple to apply and does not
require any distribution assumptions.
Results
Overview of the RNA-seq Data Sets and Paralog Analysis
We used seven bovine RNA-seq data sets, three embryonic,
and four somatic, generated by us (Jiang et al. 2014) and
downloaded from NCBI (table 2). In total, we have 40 samples
including 19 embryos and 21 tissues from all data sets.
Pearson correlation and unsupervised hierarchical clustering
(supplementary fig. S1, Supplementary Material online) show
that replicates within each tissue or embryonic stage clustered
closely to each other, suggesting even though the data were
obtained from different studies, the data were replicable and
reliable. Because we only compared the X:A ratio and gene
expression within each data set instead of across data sets, we
were able to use the data from different studies and experi-
mental platforms after data normalization. Paralogs are ho-
mologous genes within the same genome created by gene
duplication (Gevers et al. 2004). This is one potential way to
achieve X dosage compensation because X lacks a homolog
in males (Jue et al. 2013). We found an approximately 1.4-
fold increase in the percentage of paralogs (> 70% amino
acid identity [Jue et al. 2013]) on the bovine X chromosome
(33%) compared with the genome averages (24%; table 1).
This enrichment is significantly higher (table 1; P< 0.05 by
Fisher’s exact test) than to that of most chromosomes, with
the exception of chromosomes 15, 21, and 23 (P¼ 0.97,
0.10, and 0.61, respectively), suggesting the potential roles
of paralogs in X dosage compensation. Such paralog enrich-
ment on X has also been observed in humans (32% vs. 17%;
1.9-fold) and mice (51% vs. 35%; 1.5-fold) (Jue et al. 2013).
This information demonstrated that unique mapping as per-
formed in a previous RNA-seq study (Xiong et al. 2010) is not
appropriate because many paralogs will be excluded from the
analysis, and potentially skewing the X:A comparison. Thus,
we applied the “nonunique” mapping strategy for reads
mapping. Reads that aligned to multiple locations (such as
paralog gene family) in the reference genome or had alterna-
tive splice junctions were kept in all subsequent analysis. This
resulted in a total of 959 X-linked and 20,316 autosomal
protein coding genes.
Deng et al. (2011) suggested that the low and nonexpres-
sion values in RNA-seq data may result from background
noise of sequencing and read mapping. Inclusion of such
values would be inappropriate and strongly influence the
results. Furthermore, when we calculated the percentages
of X-linked and autosomal genes with low transcript per mil-
lion (TPM) values (fig. 1A and supplementary table S2,
Supplementary Material online), we found that on the aver-
age the X chromosome has 11.7% more genes with TPM 1
than autosomes. Somatic tissues including endometrium, fat,
liver, and muscle had the most enrichment of lowly expressed
X-linked genes (supplementary table S2, Supplementary
Material online). Therefore, we used a cut-off of TPM> 1 as
expressed genes to remove data bias. After this filtering, 468
X-linked genes and 12,288 autosomal genes on average were
used for X:A ratio calculation. The numbers of expressed
genes (TPM> 1) on X chromosome or autosomes in each
sample are listed in supplementary table S2, Supplementary
Material online.
Ranges of Gene Expression of All Chromosomes
We then investigated the gene expression profiles of all chro-
mosomes to determine whether the transcriptional outputs
from X chromosome were comparable to those of each au-
tosome pairs. We performed log2 transformation of TPM to
normalize the data distribution. The TPM distribution of X-
linked genes was not significantly different from those of all
autosome pairs in 11 out of 40 samples using all expressed
genes, and 31 out of 40 samples using ubiquitously expressed
genes (P> 0.05, by two-sided Kolmogorov–Smirnov test, fig.
1B and supplementary table S3, Supplementary Material on-
line). Such distributions were also demonstrated by kernel
density estimation (fig. 1C). These observations demonstrate
that regardless of the number of X chromosomes, the expres-
sion levels of ubiquitously expressed genes on X were com-
parable to those of each autosome pair in all samples,
suggesting dosage compensation.
X Chromosome Upregulation in Adult Somatic Tissues
To determine the X chromosome dosage compensation in
adult cattle tissue, we analyzed RNA-seq data sets (table 2)
for two female-specific tissues, endometrium and corpus lu-
teum, and other somatic tissues from both males and females
including the brain (hypothalamus), liver, kidney, muscle, fat,
pituitary gland, lung, and duodenum. Overall, the X:A ratios
of these tissues were in the range of 0.5–1, suggesting upre-
gulation of the expression from the X chromosome, yet the
Duan et al. GBE
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dosage compensation is incomplete (fig. 2A and B).
Specifically, the liver gave the highest X:A ratio (1.01) in
females and showed complete compensation, followed by
the pituitary gland (0.91). These data suggest that the X chro-
mosome expression was enriched for activities in these tissues.
In contrast, fat, muscle, endometrium, and the lung gave
relatively low but incomplete compensation X:A ratios
(0.64–0.72), indicating less X chromosome activities.
Furthermore, we compared the X chromosome expression
distribution between males and females in common
somatic tissues and observed no significant difference
(P> 0.05, by two-sided Kolmogorov–Smirnov test,
supplementary table S4, Supplementary Material online), ex-
cept in muscle. The X:A ratio of common tissues between
sexes was also not significantly different (P¼ 0.45, by paired
t-test after log transformation).
Although all somatic tissues we analyzed had upregulated
expression of X-linked genes which support Ohno’s hypoth-
esis, the confidence intervals of X:A ratios did not encompass
1 in most of the samples. As suggested in the previous studies
“dosage-sensitive” genes with housekeeping functions were
more likely affected by dosage imbalance and were
FIG. 1.—Expression ranges of genes on the X and autosome pairs in the bovine. (A) the averaged percentages of lowly expressed genes (TPM1) on the
X and autosomes in all samples. (B) A representative (in vivo matured oocytes) boxplot showing that the range and median expression levels of X-linked
genes (red) (TPM>1) were similar to those of each autosome pairs (blue) in the bovine. (C) A representative (in vivo matured oocyte) Kernel density plot
showing that the distribution of X-linked gene (red) expression (TPM>1) was similar to those of each autosome pairs (blue) in the bovine.
Dosage Compensation of the X Chromosomes GBE
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upregulated (Pessia, Makino, et al. 2012). When nondosage-
sensitive genes were included in the X:A calculation, the X:A
ratio were likely lower (Sangrithi et al. 2017). Therefore, we
further selected ubiquitously expressed genes (TPM> 1)
throughout all somatic samples. Gene ontology analysis
showed strong evidence that these ubiquitously expressed
genes had housekeeping roles (supplementary fig. S2,
Supplementary Material online), such as translation, RNA
transcription, protein transport, and cellular and metabolic
process (supplementary fig. S2, Supplementary Material on-
line). A total of 245 and 7,603 genes on the X chromosome
and autosomes, respectively, were included as ubiquitously
expressed genes in the recalculation of the X:A ratios (fig.
2C and D). The confidence intervals encompassed 1 and the
medians were greater than 1 in most of the samples. Brain
and its specific regions such as the pituitary gland and hypo-
thalamus had the highest X:A ratios (1.20, 1.28, and 1.22,
respectively), consistent with previous reports in other species
(Nguyen and Disteche 2006; Deng et al. 2011).
X Chromosome Upregulation in Immature and Mature
Oocytes
Germinal vesicle stage (immature) oocytes are arrested at the
diplotene stage of the first prophase of meiosis (Pro I)
(Mehlmann 2005), and contain a duplicated genome
(XXXX:AAAA) and two active X chromosomes (Fukuda
et al. 2015). The matured oocytes, on the other hand, are
arrested at the second metaphase of meiosis (MII) (Li and
Albertini 2013) and are haploid (1 N) although each homolo-
gous chromosome contains two sister chromatids/comple-
ments of DNA (2 C; XX:AA). Our analysis included immature
and both in vivo and in vitro matured oocytes (Graf et al.
2014; Jiang et al. 2014). First, we identified expressed genes
(TPM> 1) and ubiquitously expressed genes across all preim-
plantation samples. Fewer expressed ubiquitous genes were
found in these samples than in somatic tissues but similar
gene ontology terms (supplementary figs. S3 and S4,
Supplementary Material online). A total of 117 X-linked and
3,947 autosomal genes were used as ubiquitous genes for
X:A ratio calculation. Compared with expressed genes
(TPM> 1, X:A 0.75, fig. 3C), ubiquitously expressed genes
had higher X:A ratios in immature and mature oocytes at 1
and 0.87, respectively (fig. 3D). Taken together, our analyses
reveal a higher X:A ratio for ubiquitous genes, and a balanced
X to autosome expression in immature diploid oocytes and an
incomplete balance in mature haploid oocytes.
X Chromosome Upregulation in Preimplantation Embryos
X inactivation and reactivation happen in cycles during early
embryonic development. In mice, the zygote contains an in-
active X from the sperm but three X chromosome reactivation
events occur subsequently: (1) embryonic genomic activation
Table 2
The Raw FASTQ Files Generated by Us and Downloaded from NCBI GEO Database
Tissue Type (Replicates) Breed/Subspecies Number of
Samples
Library Type BioProject ID Reference
1 In vivo MII oocytes and em-
bryos: 2-, 4-, 8-, 16-, 32-cell,
CM, and BL (n¼ 2)
Holstein 8 Single-read SOLiD PRJNA254699 Jiang et al. (2014)
2 In vitro GV and MII oocytes
and embryos: 4-, 8-, 16-cell,
and BL (n¼ 3)
German Simmental ($)
and Brahman (#) cross
6 Single-read Illumina PRJNA228235 Graf et al. (2014)
3 In vivo conceptuses: days 7
(n¼ 6), 10 (n¼ 7), 13
(n¼ 5), 16 (n¼ 5), 19 (n¼ 5)
Charolais and Limousin cross 5 Single-read Illumina PRJNA243569 Mamo et al. (2012)
4 Female-speciﬁc tissue: endo-
metria (n¼ 12), corpora
lutea (n¼ 14)
Holstein 2 Paired-end Illumina PRJNA298914 Moore et al. (2016)
5 Female somatic tissues: brain,
liver, muscle, and kidney
(n¼ 4)
Bos indicusBos taurus 4 Single-read Illumina PRJNA268096 Chen et al. (2015)
6 Male somatic tissues: fat,
muscle, hypothalamus, du-
odenum, liver, lung, and
kidney (pools of 7–14
animals)
Bos taurus 7 Paired-end Illumina PRJEB6377 PRJEB6377, 2014
7 Female and male somatic tis-
sues: fat, liver, muscle, and
pituitary gland (n¼ 5)
Hanwoo (Korean cattle) 8 Paired-end Illumina PRJNA273164 Seo et al. (2016)
Duan et al. GBE
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(EGA) at 2-cell, (2) pluripotency establishment in inner cell
mass (ICM) of blastocyst, and (3) primordial germ cell gener-
ation in the genital ridge (Ohhata and Wutz 2013). Using the
bovine X-linked monomine oxidase type A (MAOA), Ferreira
et al. (2010) demonstrated that transcripts from both the ma-
ternal and paternal MAOA were present in embryos at the 4-,
8-, to 16-cell, and blastocyst stages, while only the maternal
transcripts were present in compact morula. These data
revealed that XCI occurred in an imprinted fashion in the
morula stage in the bovine and the paternal X was reactivated
at the blastocyst stage. A more permanent random XCI was
observed between the blastocyst and early elongation stages
by analyzing seven X-linked genes in day14 embryos
(Bermejo-Alvarez et al. 2011). However, the expression dy-
namics of an individual gene cannot represent the activity of
the whole X chromosome, global transcript analysis will gen-
erate a more definitive conclusion on X inactivation-
reactivation dynamics.
We therefore analyzed RNA-seq data from preattachment
embryos. In in vivo produced preimplantation embryos, we
observed an incomplete dosage compensation
(0.5<X:A< 1) using expressed genes and an excess of
compensation (X:A> 1) from the 8-cell to compact morula
stages using ubiquitous genes (fig. 3A and B). X dosage
slightly decreased after fertilization, with the lowest X:A ratio
seen at the 4-cell stage, indicating that the sperm brought in
an inactive X chromosome to the matured oocyte. The X:A
ratio started to increase from the 4- to 8-cell stage, coincident
with embryonic genome activation (EGA) for bovine in vivo
embryos (Jiang et al. 2014), suggesting that EGA actives both
paternal and maternal genome and has a more profound
effect on the X chromosome. The increased X:A ratio exhib-
ited excess compensation from the 8-cell to compact morula
stage. A sharp decrease of X:A ratio was then observed be-
tween early (32-cell) and compact morula stages, correspond-
ing to the first observed inactivation of the paternal X
chromosome in bovine embryos. The X:A subsequently stabi-
lized from days 7 to 19 of gestation, corresponding to random
XCI between the blastocyst and early elongation stages.
Using expressed genes, in vitro produced bovine preim-
plantation embryos present a similar X:A dynamics from fer-
tilization to the 8-cell stage (fig. 3C and D). However, no
excess dosage compensation was observed using ubiquitous
genes at any stage but the blastocyst, suggesting a deviation
FIG. 2.—Median X:A ratios with 95% confidence intervals of bovine female (A, B) and male (C, D) somatic tissues. The X:A ratios were calculated using
expressed (TPM>1) genes (A, C) and ubiquitously expressed (TPM>1 and present in all somatic data sets; B, D) genes. Blue line: X:A¼1, complete dosage
compensation; red line: X:A¼0.5, no dosage compensation.
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of X compensation from in vivo embryos. These observations
are consistent with recent findings of aberrant X regulation in
in vitro produced human and mouse embryos (Tan et al.
2016).
Effect of PAR and Putative XCI-Escaping Genes on X
Chromosome Upregulation
Pseudoautosomal regions (PARs) contain homologous genes
between the X and Y chromosomes, and are important in
homologous chromosome pairing and recombination during
male meiosis (Das et al. 2009). A total of 20 PAR genes (sup-
plementary table S3, Supplementary Material online) have
been characterized in bovine, sheep, goats, and other rumi-
nants (Raudsepp and Chowdhary 2015). Most PAR genes are
known to escape XCI in humans (Helena Mangs and Morris
2007). Moreover, approximately 15% and 3% of non-PAR X-
linked genes in humans and mice, respectively, are known to
escape XCI (Berletch et al. 2011). In the bovine, 55 such X-
linked genes (supplementary table S5, Supplementary
Material online) were classified as candidates that escape
XCI (Ka et al. 2016). To tease out the effects of these bi-
allelically expressed PAR genes and XCI-escaping genes,
we plotted X:A ratios in the categories of “all genes,”
“expressed genes,” “genes subjected to XCI (excluding
PAR genes and putative XCI-escaping genes),” and
“dosage-sensitive genes” (fig. 4). The X:A ratios for “all
genes” had the median value closer to 0.5, while the ra-
tios for “expressed genes” were closer to 1. When we
excluded PARs and putative XCI-escaping genes from
“expressed genes,” the outliers of extremely high X:A
ratios disappeared, suggesting bi-allelically expressed
X-linked genes did contribute to the high X:A ratios.
Moreover, “dosage-sensitive genes” maintained the high-
est X:A ratios (> 1), further confirming the hyperexpres-
sion nature of this subgroup of genes.
Discussion
In this study, we determined the X chromosome dosage pro-
files in four chromosome scenarios in the bovine. Immature
oocytes represent diploid germline with duplicated genome/
FIG. 3.—Median X:A ratios with 95% confidence intervals of bovine in vivo (A, B) and in vitro (C, D) produced oocytes and pre- and postimplantation
embryos. The X:A ratios were calculated using expressed (TPM>1) genes (A, C) and ubiquitously expressed (TPM>1 and present in all embryo data sets; B,
D). GV, germinal vesicle; MII, metaphase of second meiosis; CM, compact morula; BL, blastocyst. Blue line: X:A¼1, complete dosage compensation; red
line: X:A¼0.5, no dosage compensation.
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four complements of DNA (XXXX:AAAA); mature oocyte rep-
resent haploid germline with duplicated genome/two comple-
ments of DNA (XX:AA); bovine preimplantation embryos at
various stages represent the gradual change from two active
X (XaXa:AA) to one inactive X chromosome (XaXi:AA); female
and male somatic tissues contain diploid cells with one already
inactivated X (XaXi:AA or XY:AA). Our analyses showed in-
complete compensation (0.5<X:A< 1) of X chromosome to
autosome pairs in all scenarios for expressed genes (TPM> 1)
and excess compensation (X:A> 1) for “dosage-sensitive”
genes in somatic tissues and certain stages in early embryos.
These findings suggest that X dosage upregulation occurs in
bovine germlines, preattachment embryos, and somatic tis-
sues analyzed here.
Our results in bovine are consistent with previous findings
in other mammalian species using similar strategies of data
filtering (Deng et al. 2011; Pessia, Makino, et al. 2012).
However, studies applying different threshold criteria on
RNA-seq data generated conflicting results for mammalian
X dosage compensation. Xiong et al. (2010) included genes
with low and no expression and reported X:A ratio close to
0.5. Whereas many follow-up studies reanalyzing the same
RNA-seq data after removing the “noise” concluded hyper-
activation of X on expressed genes (Deng et al. 2011), espe-
cially dosage-sensitive ones (genes encoding protein complex
of seven or more members and having housekeeping roles)
(Pessia, Makino, et al. 2012). Thus, dosage compensation,
unlike XCI, has been proposed to be a local process with
hyper-expression by only dosage-sensitive genes (Pessia,
Engelst€adter, et al. 2014). In our study, we applied two
gene selection methods in order to identify “dosage-
sensitive” genes: expressed genes that are TPM> 1 and ubiq-
uitous genes whose TPM’s are> 1 in all somatic samples or in
all embryo samples. We found similar results as in humans
and mice that incomplete dosage compensation was incom-
plete in most scenarios when expressed genes were used,
while ubiquitous genes had a higher X dosage, implying
that the expression of a group of X-linked bovine genes are
collectively more than doubled. Furthermore, this level of
upregulation could not be globally applied to all genes on
the X chromosome.
The previous study by Xiong et al. (2010) filtered out reads
that mapped to multiple locations of the genome and those
that spanned splice junctions. Their unique mapping ap-
proach resulted in X:A ratio close to 0.5 and refuted the X
dosage compensation conclusion. Multiple groups
(Kharchenko et al. 2011; Pessia, Makino, et al. 2012) have
re-analysis the data from Xiong et al. by different mapping
strategy and reached opposite conclusions. Jue et al. (2013)
showed that mapping strategies can significantly impact the
conclusions regarding X:A ratios. The “unique” mapping
strategy can remove reads from close paralogs which affects
the X chromosome substantially (Jue et al. 2013). Considering
this point, here we used nonunique mapping strategy. We
used the Hisat2 software that by default reports both uniquely
and multimapped reads Hisat2 is known to have the highest
correctly multimapped reads compared with other aligners
(Kim et al. 2015).
Bovine female somatic tissues had a slightly higher X:A
ratio than the same tissues of males. This difference, however,
was not significantly different (P¼ 0.45). X chromosome ex-
pression distribution was also similar between sexes
(P> 0.05). These demonstrated that the expression of the X
chromosome is balanced between males and females al-
though they have different numbers of the X chromosome.
The slightly higher X:A ratio in females may be a result of
genes that escape XCI (Couldrey et al. 2017). Although it is
unclear how many genes escape XCI in the bovine, a previous
report documented a few X-linked genes escaping XCI in a
mosaic fashion in the bovine (Yen et al. 2007).
The brain tissue had the highest X:A ratio compared with
the other tissues, consistent with previous RNA-seq studies in
several mammalian species (Nguyen and Disteche 2006; Deng
et al. 2011). This could be related to the fact that may genes
related to brain functions, such as MAOA, are located on the
X chromosome (Zechner et al. 2001). On the contrary, X dos-
age of other bovine somatic tissues including fat, liver, muscle,
and the pituitary gland was previously determined as incom-
pletely compensated (Ka et al. 2016), which is consistent with
results in humans, mice, and ours.
Germ cells and the developing embryos undergo drastic
epigenetic changes. We observed balanced expression of the
X chromosome with that of the autosomes in diploid
FIG. 4.—Boxplot of the X:A medians for all data sets. Genes were
categorized in “all genes,” “expressed (TPM>1) genes,” “genes sub-
jected to XCI (excluding PAR genes and putative XCI-escaping genes),”
and “dosage-sensitive (ubiquitously expressed) genes.” Blue line: X:A¼1,
complete dosage compensation; red line: X:A¼0.5, no dosage
compensation.
Dosage Compensation of the X Chromosomes GBE
250 Genome Biol. Evol. 11(1):242–252 doi:10.1093/gbe/evy270 Advance Access publication December 19, 2018
D
ow
nloaded from
 https://academ
ic.oup.com
/gbe/article-abstract/11/1/242/5253178 by Louisiana State U
niversity user on 14 N
ovem
ber 2019
immature oocytes and incomplete balance in haploid matured
oocytes. These data are consistent with those by Fukuda et al.
who also showed higher dosage compensation of X chromo-
some in immature than matured oocytes in the human and
mouse (Fukuda et al. 2015). However, X:A ratio slightly de-
creased after fertilization probably due to the sperm brings in
some mRNAs of autosomal origin in addition to an inactive X
(Huynh and Lee 2003). Because early embryonic development
is primarily dependent on stored maternal mRNAs and pro-
teins which gradually degrade until EGA (Memili and First
2000), a consistent decrease and then increase of X:A before
and after EGA, respectively, were observed. The timing of the
changes in X:A in in vivo embryos, however, was one cell cycle
earlier than their in vitro counterparts due to the timing dif-
ference between these two types of embryos, which are 4–
8 and 8–16 cell stages, respectively (Telford et al. 1990;
Misirlioglu et al. 2006; Kues et al. 2008; Graf et al. 2014;
Jiang et al. 2014).
Conclusion
In conclusion, our study shows the upregulation of X chro-
mosome in four bovine genome scenarios, supporting a bal-
anced expression between a single active X and autosome
pairs. However, deviating from Ohno’s theory, dosage com-
pensation to rescue X haploinsufficiency appears to be an
incomplete process for expressed genes but a complete pro-
cess for “dosage-sensitive” genes. Removal of PAR genes and
those putatively escape XCI eliminated the outliers of ex-
tremely high X:A ratios. In addition, the switch from imprinted
XCI at the compact morula stage to random XCI at the blas-
tocyst stage may happen so rapidly that the potential transient
state of two active X chromosomes could not be captured in
the current data set with limited time points. Whether a tran-
sient two active X state occurs or not during blastulation
requires frequent sampling and further study. Lastly, no rela-
tive X expression difference was observed between bovine
female and male somatic tissues, suggesting Ohno’s hypoth-
esis balanced the overall X between sexes.
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